[DOI] [PubMed] [Google Scholar] 21.Canapp SO, Jr, Farese JP, Schultz GS, Gowda S, Ishak AM, Swaim SF, Vangilder J, Lee-Ambrose L, Martin FG
As a compounded medication, this product is not evaluated by the United States Food and Drug Administration for safety or efficacy, and clinical use should therefore be guided by careful patient selection, informed consent, and ongoing monitoring to ensure that the lowest effective dose is employed for the shortest duration compatible with therapeutic goals
A more recent meta-analysis of randomized, controlled trials published in Obesity Research and Clinical Practice confirmed these findings, reporting that tesamorelin significantly reduced visceral fat, trunk fat, hepatic fat and waist circumference, while increasing lean body mass in adults with HIV-associated lipodystrophy
10.1016/j.cub.2019.11.079 Curr